More Than Half Today's Children Expected to Be Obese at 35

Share this content:
More Than Half Today's Children Expected to Be Obese at 35
More Than Half Today's Children Expected to Be Obese at 35

THURSDAY, Nov. 30, 2017 (HealthDay News) -- More than half of today's children are expected to be obese at the age of 35 years, with about half of the prevalence occurring during childhood, according to a study published in the Nov. 30 issue of the New England Journal of Medicine.

Zachary J. Ward, M.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues estimated the risk of adult obesity at age 35 years for the current population of children in the United States. Height and weight data were pooled from five nationally representative longitudinal studies with 176,720 observations from 41,567 children and adults.

The researchers found that the models predicted that 57.3 percent of today's children will be obese at the age of 35 years, given the current level of childhood obesity; about half of the projected prevalence will occur during childhood. The relative risk of adult obesity increased with age and body mass index, from 1.17 for overweight 2-year-olds to 3.10 for severely obese 19-year-olds. The chance that children with severe obesity will no longer be obese at the age of 35 years decreased from 21.0 percent at the age of 2 years to 6.1 percent at the age of 19 years.

"On the basis of our simulation models, childhood obesity and overweight will continue to be a major health problem in the United States," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Lab  Companion Tests Perform Similarly for Oncology Analytes

Lab + Companion Tests Perform Similarly for Oncology ...

Findings based on comparison of tests to diagnose oncology-related genetic variants

Ulixertinib Is Active in Patients With Advanced Solid Tumors

Ulixertinib Is Active in Patients With Advanced Solid ...

Responses occurred in patients with NRAS-, BRAF V600-, non-V600 BRAF-mutant solid tumors

Doctors Must Report on at Least 1 Patient, 1 Measure for MACRA

Doctors Must Report on at Least 1 Patient, ...

To avoid Medicare payment penalty in 2019, clinicians must report by Dec. 31, submit by Feb. 28

is free, fast, and customized just for you!

Already a member?

Sign In Now »